ArticleInternational journal of legal medicine2025
Post-mortem urine dipstick analysis for hyperglycemia and ketoacidosis: observer agreement and diagnostic value.
Article in International journal of legal medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The post-mortem diagnosis of hyperglycemia and/or ketoacidosis is challenging and usually requires costly ancillary testing of vitreous humor or serum samples. A screening tool that would help to determine whether ancillary testing is needed is therefore desirable. The aim of this study was to add to the literature testing the validity and diagnostic utility of post-mortem dipstick urinalysis. More specifically, we determined inter-observer agreement of visual dipstick assessment, the correlation between glucose and ketone urine dipstick scores and formal laboratory testing results, and the diagnostic value of specific dipstick scores expressed with likelihood ratios. Results demonstrate almost perfect interobserver agreement for 108 glucose dipstick scores (Fleiss' kappa 0.914) but only moderate interobserver agreement for 96 ketones dipstick scores (Fleiss' kappa 0.467). Dipstick glucose scores correlated strongly with vitreous humor glucose levels (Spearman's rank correlation coefficient of 0.841, n = 107). Correlation between ketone dipstick scores and serum levels of beta-hydroxybutyrate (BHB) and blood acetone was also positive but much weaker (0.317, n = 91; and 0.411, n = 92, respectively). The diagnostic value of specific dipstick scores was determined by calculating likelihood ratios for substantial hyperglycemia (vitreous humor glucose > 10 mmol/L), substantial ketoacidosis (serum BHB > 2.50 mmol/L) and elevated blood acetone (> 20 mg/L). Our results suggest substantial screening potential of dipstick urinalysis for glucose, especially when scores are at the lower and higher end of the spectrum. Overall, dipstick analysis results for ketones must be interpreted with great caution. A sub analysis of the data showed that a serum BHB above 2.50 mmol/L was only seen in 1.8% of cases without demonstrable acetone (> 20 mg/L).
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.